1. Home
  2. LNSR vs RPTX Comparison

LNSR vs RPTX Comparison

Compare LNSR & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNSR
  • RPTX
  • Stock Information
  • Founded
  • LNSR 2004
  • RPTX 2016
  • Country
  • LNSR United States
  • RPTX Canada
  • Employees
  • LNSR N/A
  • RPTX N/A
  • Industry
  • LNSR Medical Electronics
  • RPTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNSR Health Care
  • RPTX Health Care
  • Exchange
  • LNSR Nasdaq
  • RPTX Nasdaq
  • Market Cap
  • LNSR N/A
  • RPTX 38.3M
  • IPO Year
  • LNSR N/A
  • RPTX 2020
  • Fundamental
  • Price
  • LNSR $13.81
  • RPTX $1.36
  • Analyst Decision
  • LNSR Hold
  • RPTX Strong Buy
  • Analyst Count
  • LNSR 1
  • RPTX 3
  • Target Price
  • LNSR $15.00
  • RPTX $4.50
  • AVG Volume (30 Days)
  • LNSR 130.3K
  • RPTX 508.5K
  • Earning Date
  • LNSR 05-08-2025
  • RPTX 05-20-2025
  • Dividend Yield
  • LNSR N/A
  • RPTX N/A
  • EPS Growth
  • LNSR N/A
  • RPTX N/A
  • EPS
  • LNSR N/A
  • RPTX N/A
  • Revenue
  • LNSR $57,065,000.00
  • RPTX $53,477,000.00
  • Revenue This Year
  • LNSR $29.95
  • RPTX N/A
  • Revenue Next Year
  • LNSR $29.35
  • RPTX $7.14
  • P/E Ratio
  • LNSR N/A
  • RPTX N/A
  • Revenue Growth
  • LNSR 26.87
  • RPTX 4.58
  • 52 Week Low
  • LNSR $3.21
  • RPTX $0.89
  • 52 Week High
  • LNSR $17.31
  • RPTX $4.29
  • Technical
  • Relative Strength Index (RSI)
  • LNSR 49.37
  • RPTX 59.23
  • Support Level
  • LNSR $13.65
  • RPTX $1.25
  • Resistance Level
  • LNSR $14.12
  • RPTX $1.48
  • Average True Range (ATR)
  • LNSR 0.14
  • RPTX 0.11
  • MACD
  • LNSR -0.03
  • RPTX 0.01
  • Stochastic Oscillator
  • LNSR 26.23
  • RPTX 57.14

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Share on Social Networks: